DNA TOPOISOMERASE POISONS AS ANTITUMOR DRUGS

被引：2014
|
作者：
LIU, LF
机构：
来源：
ANNUAL REVIEW OF BIOCHEMISTRY | 1989年 / 58卷
关键词：
D O I：
10.1146/annurev.bi.58.070189.002031
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
引用
收藏
页码：351 / 375
页数：25
相关论文
共 50 条
  • [41] Drugs and poisons
    Stankus, T
    SERIALS LIBRARIAN, 1995, 27 (2-3): : 87 - 102
  • [42] Antitumor drugs possessing topoisomerase I inhibition: applicable separation methods
    Oguma, T
    JOURNAL OF CHROMATOGRAPHY B, 2001, 764 (1-2): : 49 - 58
  • [43] DNA DAMAGE BY ANTITUMOR ACRIDINES MEDIATED BY MAMMALIAN DNA TOPOISOMERASE-II
    ROWE, TC
    CHEN, GL
    HSIANG, YH
    LIU, LF
    CANCER RESEARCH, 1986, 46 (04) : 2021 - 2026
  • [44] Novel antitumor indenbindole derivatives targeting DNA and topoisomerase II
    Bal, C
    Baldeyrou, B
    Moz, F
    Lansiaux, A
    Colson, P
    Kraus-Berthier, L
    Lóence, S
    Pierré, A
    Boussard, MF
    Rousseau, A
    Wierzbicki, M
    Bailly, C
    BIOCHEMICAL PHARMACOLOGY, 2004, 68 (10) : 1911 - 1922
  • [45] DNA TOPOISOMERASE-II AS THE PRIMARY TARGET OF ANTITUMOR ANTHRACYCLINES
    ZUNINO, F
    CAPRANICO, G
    ANTI-CANCER DRUG DESIGN, 1990, 5 (04): : 307 - 317
  • [46] Bis(2,6-dioxopiperazines), catalytic inhibitors of DNA topoisomerase II, as molecular probes, cardioprotectors and antitumor drugs
    Andoh, T
    BIOCHIMIE, 1998, 80 (03) : 235 - 246
  • [47] UBC9 functions to protect cells from DNA topoisomerase I poisons
    Jacquiau, HR
    van Waardenburg, RCAM
    Reid, RJD
    Bjornsti, MA
    YEAST, 2003, 20 : S113 - S113
  • [48] Luteolin, an emerging anti-cancer flavonold, poisons eukaryotic DNA topoisomerase I
    Chowdhury, AR
    Sharma, S
    Mandal, S
    Goswami, A
    Mukhopadhyay, S
    Majumder, HK
    BIOCHEMICAL JOURNAL, 2002, 366 (02) : 653 - 661
  • [49] EVIDENCE FOR THE REVERSIBILITY OF CELLULAR DNA LESION INDUCED BY MAMMALIAN TOPOISOMERASE-II POISONS
    HSIANG, YH
    LIU, LF
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1989, 264 (17) : 9713 - 9715
  • [50] DNA topoisomerase targeting drugs: mechanisms of action and perspectives
    Malonne, H
    Atassi, G
    ANTI-CANCER DRUGS, 1997, 8 (09) : 811 - 822
12345